Vaccines, blood, antisera, toxins and cultures in Canada | The Observatory of Economic Complexity

About

Exports In 2023, Canada exported $1.06B in Vaccines, blood, antisera, toxins and cultures, making it the 21st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 85th most exported product in Canada. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Canada are: United States ($655M), France ($86.2M), Norway ($67.1M), Belgium ($36.1M), and United Kingdom ($30.1M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Canada between 2022 and 2023 were United States ($151M), France ($50.5M), and Italy ($17.7M).

Imports In 2023, Canada imported $6.69B in Vaccines, blood, antisera, toxins and cultures, becoming the 12th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 10th most imported product in Canada. Canada imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($2.09B), Switzerland ($974M), Germany ($870M), Ireland ($787M), and Belgium ($693M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Canada between 2022 and 2023 were Ireland ($159M), Germany ($73.5M), and Sweden ($60.9M).

Latest Trends

November 2024

About

Overview In November 2024 Canada's Vaccines, blood, antisera, toxins and cultures exports accounted up to C$116M and imports accounted up to C$694M, resulting in a negative trade balance of C$579M. Between November 2023 and November 2024 the exports of Canada's Vaccines, blood, antisera, toxins and cultures have increased by C$17.7M (18%) from C$98.2M to C$116M, while imports decreased by C$-41.3M (-5.61%) from C$736M to C$694M.

Destinations In November 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States (C$70.4M), France (C$27.7M), South Korea (C$2.02M), Australia (C$1.96M), and Turkey (C$1.72M), and were imported mostly from United States (C$253M), Germany (C$87.8M), Belgium (C$74.1M), Switzerland (C$72.6M), and Italy (C$55.3M).

Growth In November 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to United States (C$24.5M or 240%), France (C$10.8M or 2.16k%), and South Korea (C$683k or 45%). In November 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from United States (C$-371M or -67.6%), Belgium (C$-187M or -73.4%), and South Korea (C$-137M or -89.1%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (November 2023 - November 2024)C$17.7M(18%)

IMPORT GROWTH (November 2023 - November 2024)C$-41.3M(-5.61%)

MAIN EXPORTER (November 2024)OntarioC$88.5M

MAIN DESTINATION (November 2024)United StatesC$70.4M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Canada. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download